Mohs surgery was created by Dr. Frederic E. Mohs. Originally developed in the 1930s, Mohs surgery is microscopically controlled surgery used to treat common types of skin cancer. Mohs micrographic surgery has been refined into the most advanced, precise and effective treatment for an increasing variety of skin cancer types.
During the surgery, after each removal of tissue, while the patient waits, the surgeon examines the tissue specimen for skin cancer cells, and that examination informs the surgeon where to remove tissue next. Mohs surgery allows for the removal of a skin cancer with very narrow surgical margin and a high cure rate. Because the Mohs procedure is micrographically controlled, it provides precise removal of the cancerous tissue, while healthy tissue is spared.
Mohs surgery is unique and so effective because it evaluates 100 per cent of the surgical margins. The pathologic interpretation of the tissue margins is done on site by the Mohs surgeon, who is specially trained in the reading of these slides and is best able to correlate any microscopic findings with the surgical site on the patient. Advantages of Mohs surgery include:
Other skin cancer treatment methods blindly estimate the amount of tissue to treat, which can result in the unnecessary removal of healthy skin tissue and cancer re-growth.